"According to a press release, California-based Nevro will grant Massachusetts-based Boston Scientific a worldwide, non-exclusive, non-transferable licence to practice paresthesia-free therapy, while also promising not to sue for any features embodied in any current Boston Scientific products for frequencies below 1,500 Hz. In return, Boston Scientific will also grant Nevro a worldwide, non-exclusive, non-transferable licence under Boston Scientific’s asserted patent families and a covenant not to sue.
Under the settlement, Boston Scientific will pay Nevro $85 million. However, a US court awarded Boston Scientific $20 million in damages in 2021 because Nevro infringed two of its competitor’s patents."
Sterne, Kessler, Goldstein & Fox was mentioned as Nevro's representation in the article "Nevro and Boston Scientific Call Truce in Spinal-Stimulation Technology Dispute," published by JUVE Patent. The team was led by Director Jon E. Wright and includes Counsel Richard A. Crudo and Associate Ian Soule.